Patak R V, Mookerjee B K, Bentzel C J, Hysert P E, Babej M, Lee J B
Prostaglandins. 1975 Oct;10(4):649-59. doi: 10.1016/s0090-6980(75)80012-8.
Furosemide and the prostaglandin synthetase inhibitor, indomethacin, were administered singly and in combination to four normal subjects and six patients with essential hypertension in order to determine whether the antihypertensive, natriuretic and other effects of furosemide could be altered by inhibition of prostaglandin synthesis. In all subjects indomethacin treatment alone resulted in a significant elevation of blood pressure and a fall in plasma renin without any change in sodium excretion. Furosemide alone resulted in a significant blood pressure fall with a rise in plasma renin and urinary aldosterone with a marked increase in urinary sodium loss. These effects were either obviated or blunted by addition of indomethacin. The results are compatible with hypothesis that the antihypertensive and natriuretic effects of furosemide might be mediated at least in part by prostaglandin synthesis. In addition, the effects of indomethacin should be considered when using this drug in hypertensive patients and in subjects requiring diuretic therapy.
为了确定抑制前列腺素合成是否会改变速尿的降压、利钠及其他作用,对4名正常受试者和6名原发性高血压患者单独及联合给予速尿和前列腺素合成酶抑制剂吲哚美辛。在所有受试者中,单独使用吲哚美辛治疗会导致血压显著升高和血浆肾素水平下降,而钠排泄无任何变化。单独使用速尿会导致血压显著下降,血浆肾素和尿醛固酮水平升高,尿钠丢失显著增加。添加吲哚美辛后,这些作用要么被消除,要么被减弱。结果与以下假设相符,即速尿的降压和利钠作用可能至少部分由前列腺素合成介导。此外,在高血压患者和需要利尿治疗的受试者中使用吲哚美辛时,应考虑其作用。